Cited by 1,116Genomics and Rare DiseasesGenomics and Phylogenetic StudiesArtificial Intelligence in Healthcare and Education

Towards precision medicine

Ashley, Euan A.·2016·Nature Reviews Genetics

Abstract

There is great potential for genome sequencing to enhance patient care through improved diagnostic sensitivity and more precise therapeutic targeting. To maximize this potential, genomics strategies that have been developed for genetic discovery - including DNA-sequencing technologies and analysis algorithms - need to be adapted to fit clinical needs. This will require the optimization of alignment algorithms, attention to quality-coverage metrics, tailored solutions for paralogous or low-complexity areas of the genome, and the adoption of consensus standards for variant calling and interpretation. Global sharing of this more accurate genotypic and phenotypic data will accelerate the determination of causality for novel genes or variants. Thus, a deeper understanding of disease will be realized that will allow its targeting with much greater therapeutic precision.

Integrity signals

Registry

Crossref · 10.1038/nrg.2016.86

Cites

134 of 134 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ashley, E. A.
Affiliations
Stanford Health Care (US)
Corresponding author
Ashley, Euan A.
Venue
Nature Reviews Genetics
Published
2016-08-16
Volume
17
Issue
9
Pages
507-522
ISSN
  • 1471-0056 (ISSN-L)
  • 1471-0064
OpenAlex
W2513408092
Cited by
1,116
References
134
Citations by year
2026: 150 · 2025: 145 · 2024: 161 · 2023: 113 · 2022: 124 · 2021: 102 · 2020: 101 · 2019: 75 · 2018: 68 · 2017: 70 · 2016: 6 · 2014: 1
FWCI
9.76
Type
journal article
Language
en
Open access
closed
Locations
  • Nature Reviews Genetics (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institutes of Health
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Phylogenetic Studies
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
Keywords
precision medicine, clinical genomics, genome sequencing, variant interpretation, bioinformatics pipeline, alignment algorithms, sequencing quality metrics, low complexity regions, genetic diagnosis, therapeutic targeting, data sharing
MeSH terms
Algorithms, Genotype, Humans, Software, Sequence Analysis, DNA, Genomics, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review